FDA Cleared KARL STORZ Cardiac Endoscope

The TIPCAM1 Rubina device has received clearance for use in minimally invasive cardiac surgical procedures.

Updated on Sept. 29, 2026 in Heart Disease

Bold flat-color editorial illustration of a surgical endoscope tip, rendered as a high-contrast geometric symbol in navy and cream. — The U.S. Food and Drug Administration granted 510(k) clearance for the KARL STORZ TIPCAM1 Rubina, a video endoscope for minimally invasive cardiac surgery. AI Illustration. Upload story photo >

Live Poll

Do you trust that new medical technology advancements are making complex heart surgeries safer?

The U.S. Food and Drug Administration has granted clearance for the TIPCAM1 Rubina video endoscope. This device is designed to assist surgeons during complex cardiac interventions.

Why it matters

The clearance provides surgeons with advanced visualization tools intended to improve workflow efficiency and consistency during intricate cardiac procedures.

The TIPCAM1 Rubina integrates 4K resolution, stereoscopic 3D imaging, and near-infrared fluorescence into one system. It also features Horizon Control technology to maintain image orientation during scope rotation.

The players

U.S. Food and Drug Administration

The federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of medical devices.

KARL STORZ

A family-owned medical technology company based in Germany that manufactures endoscopic imaging systems for various surgical specialties.

The details

The device is cleared for use in procedures including mitral and tricuspid valve repairs, as well as structural heart interventions and internal mammary artery mobilization. By consolidating multiple high-definition imaging capabilities, the system aims to support surgeons throughout minimally invasive operations.

September 29, 2026: The FDA granted regulatory clearance for the medical device.

Robotics
Sept. 28
FDA Authorized Johnson & Johnson Surgical Robot
Healthcare
Sept. 22
TriSalus Life Sciences Received FDA Clearance
Artificial Intelligence
Sept. 21
FDA Cleared New AI Tool for CT Scan Triage

The Big Picture

This story follows the standard regulatory path established by the FDA 510(k) clearance process for class II medical devices, which allows for the marketing of devices shown to be substantially equivalent to others. The clearance marks the successful completion of the standard FDA 510(k) review process for this specific piece of surgical equipment.

Patients undergoing minimally invasive cardiac surgeries may benefit from the improved visualization and precision offered by this new technology. These advancements aim to support more consistent surgical outcomes during complex structural heart repairs.

The takeaway

Advanced imaging technologies continue to play a critical role in the evolution of minimally invasive heart surgery. Surgeons utilizing these tools can achieve greater orientation stability and clearer visual feedback during high-stakes medical interventions.